title: Treatment of Retinal Disorders with Purinergic Drugs: Beyond Receptors.
authors.affiliation: 1 Department of Biological Science, University of Pittsburgh , Pennsylvania.
authors.forename: Jonathan M
authors.initials: JM
authors.lastname: Beckel
authors.affiliation: 2 Department of Anatomy and Cell Biology, University of Pennsylvania , Philadelphia, Pennsylvania.
authors.forename: Wennan
authors.initials: W
authors.lastname: Lu
authors.affiliation: 3 Department of Physiology, University of Pennsylvania , Philadelphia, Pennsylvania.
authors.forename: Mortimer M
authors.initials: MM
authors.lastname: Civan
authors.affiliation: 2 Department of Anatomy and Cell Biology, University of Pennsylvania , Philadelphia, Pennsylvania.|3 Department of Physiology, University of Pennsylvania , Philadelphia, Pennsylvania.
authors.forename: Claire H
authors.initials: CH
authors.lastname: Mitchell
mesh_terms: D000818:Animals; D006801:Humans; D058913:Purinergic Agonists / Q000008:administration & dosage*; D058914:Purinergic Antagonists / Q000008:administration & dosage*; D011983:Receptors, Purinergic / Q000502:physiology*; D012160:Retina / Q000187:drug effects / Q000502:physiology; D012164:Retinal Diseases / Q000188:drug therapy*; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D016896:Treatment Outcome
chemical_list: D058913:Purinergic Agonists; D058914:Purinergic Antagonists; D011983:Receptors, Purinergic